WASHINGTON — Pharmaceutical giant Johnson & Johnson on Tuesday became the third drugmaker to sue the Biden administration over its new Medicare drug price negotiation program.
BESSY II’s high-brilliance X-rays can be used to produce microscopic images with spatial resolution down to a few tens of nanometers.
Francesca Marassi, PhD, professor and chair of biophysics at the Medical College of Wisconsin (MCW), has been awarded a five-year, $13 million program project grant
New research is tackling the mental health crisis in the construction industry – highlighting the benefits of an on-site Health Hub on worker wellbeing.
A group of 20 patients with undiagnosed neurodevelopmental disorders ranging from severe to mild has now received a genetic diagnosis thanks to an international team
Dive Brief: Masimo said Monday its second-quarter revenue would be below expectations after large orders from hospitals were delayed, prompting the maker of pulse oximeters
Dive Brief: Big Health has bought Limbix to add a treatment for adolescent depression to its portfolio of digital therapeutics. The app, SparkRx, uses self-guided,
Dive Brief: ViewRay, a Denver-based company that makes an MRI-guided radiation therapy system to treat cancer patients, filed for Chapter 11 bankruptcy on Monday. Inflation
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET. Now that biosimilar versions of Humira are starting to arrive, what
A handful of entities are in various stages of the FDA approval process for MDMA and psilocybin drugs (see here and here for some of our prior analysis